Highly multiplexed spatial biomarker analysis has demonstrated the potential to advance our current understanding of the immune system and its role in cancer. Previously, a trade-off between plex and spatial context meant that our understanding of immune cell involvement in cancer was limited by either single-plex technologies with spatial context (e.g., immunohistochemistry) or highly multiplexed technologies without spatial context (e.g., single-cell RNA sequencing).
Download this poster to discover a platform that can:
- Generate highly-multiplexed, spatially-resolved protein expression data from a clinical sample
- Quantify cell populations expressing very high or low levels of a single marker
- Use commercial antibodies from any vendor to spatially resolve protein targets in situ
